Table 1 Baseline characteristics of the study cohorts for Stroke, AMI and Tuberculosis used for evaluating our simulation approach

N

367,768

359,625

2,073

Age at Diagnosis (n (%))

18–30

17,972 (4.89%)

4,174 (1.16%)

252 (12.16%)

31–45

61,820 (16.81%)

45,835 (12.75%)

620 (29.91%)

46–55

121,995 (33.17%)

131,604 (36.59%)

588 (28.36%)

>55

165,981 (45.13%)

178,012 (49.50%)

613 (29.57%)

Sex (n (%))

Male

186,966 (50.84%)

249,899 (69.49%)

988 (47.66%)

Female

180,802 (49.16%)

109,726 (30.51%)

1,085 (52.34%)

Enrollment Time Prior to Index (years)

Mean

3.62

3.70

3.86

Median

2.60

2.65

2.87

Range

0.49–17.01

0.49–17.01

1.00–15.79

Count ≥ 1 year (n (%))

306,800 (83.42%)

302,026 (83.98%)

2,073 (100.00%)

Count ≥ 1.5 years (n (%))

260,581 (70.85%)

257,661 (71.65%)

1,719 (82.92%)

Count ≥ 2 years (n (%))

221,360 (60.19%)

219,651 (61.08%)

1,419 (68.45%)

Count ≥ 3 years (n (%))

162,047 (44.06%)

161,224 (44.83%)

997 (48.09%)

Number of Visits in Period Prior to Diagnosis (i.e. 365 days prior for tuberculosis and 180 days prior for stroke and AMI) (n (%))

0

52,737 (14.34%)

63,141 (17.56%)

52 (2.51%)

1–5

124,630 (33.89%)

137,677 (38.28%)

251 (12.11%)

6–10

71,075 (19.33%)

66,292 (18.43%)

345 (16.64%)

11–20

64,189 (17.45%)

52,606 (14.63%)

606 (29.23%)

> 20

55,137 (14.99%)

39,909 (11.10%)

819 (39.51%)